- Display 45 Products per page
Published: June 25, 2025 | Price: $5,600.00 – $8,000.00
Updated quarterly (four times a year) to reflect market changes Kalorama Information’s 30-Country IVD Market Atlas, 2025 provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030, and quarterly updates throughout 2025, ensuring timely insights into the evolving global IVD landscape. Leveraging over two decades of...Published: June 24, 2025 | Price: $5,250.00 – $7,500.00
The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions. As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater. In Vitro Diagnostics Business...Published: May 13, 2025 | Price: $8,400.00 – $12,000.00
Now in its twelfth edition — Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the POC market from a global perspective with a five-year forecast. Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition provides a comprehensive analysis of the global POC diagnostics market, with forecasts extending through 2029. While traditional lab-based analyzers remain central to the in vitro diagnostics (IVD) industry, the POC segment has emerged as a dynamic growth area, driven by the demand for rapid, accessible testing across diverse healthcare...Published: April 2, 2025 | Price: $7,700.00 – $11,000.00
Important Note: The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports. Stay Ahead with the Latest Information: Subscribers will receive data updates after each financial quarter for one year, totaling four updates (Q4 2024, Q1 2025, Q2 2025, Q3 2025). These updates are provided in an Excel spreadsheet, making them easily...Published: March 4, 2025 | Price: $5,600.00 – $8,000.00
Molecular point-of-care (mPOC) diagnostics are revolutionizing the in vitro diagnostics (IVD) landscape, delivering the sensitivity and specificity of molecular testing with the accessibility and speed of traditional point-of-care (POC) solutions. Kalorama Information’s latest report, Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 2024-2029, provides a comprehensive analysis of this rapidly evolving market, covering the size, growth trajectory, and competitive dynamics forecasted over a five year span to 2029. Market Drivers & Opportunities mPOC has transitioned from an emerging innovation to a major...Published: December 23, 2024 | Price: $5,000.00 – $10,500.00
Now in its fourth and final update in 2024! What’s Included One Report Covering 30 Countries Sizing for 20 Important IVD Market Segments Segments Estimated for Each Country Forecasts to 2028 for Each Segment Updated Quarterly (4 updates annually) to Reflect Market Changes Over 2800 Data Points About the Report With over two decades of experience in publishing in vitro diagnostic (IVD) market research, Kalorama Information understands the importance of global coverage and the need for more detailed geographic...Published: December 19, 2024 | Price: $3,950.00 – $7,875.00
The molecular diagnostics market, a driving force within the global in vitro diagnostics (IVD) industry, continues to thrive several years post-pandemic, offering significant growth opportunities across infectious diseases, cancer, and transplant diagnostics. Kalorama Information's latest report, The World Market for Molecular Diagnostics, 13th Edition, provides an unparalleled deep dive into this dynamic sector, revealing key trends, applications, and innovations shaping the market from 2024 to 2029. Why This Report is a Must-Have: Comprehensive Market Insights: Analyze global and regional molecular...Published: December 6, 2024 | Price: $5,000.00 – $10,500.00
The in vitro diagnostics (IVD) market has demonstrated robust growth, driven by technological advancements and expanding opportunities. Diagnostic testing has evolved from merely diagnosing illnesses to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product developments, shifts in global health spending, regulatory changes, and disease trends, maintaining its resilience. Several segments within the IVD market are experiencing significant growth and...Published: November 30, 2024 | Price: $10,500.00
NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report. All in any edition. This is because this is a quarterly update to markets covered in these reports. The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel spreadsheet...Published: November 25, 2024 | Price: $5,000.00 – $10,500.00
The U.S. IVD market is a cornerstone of global healthcare innovation—but it is also a market in transition In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029, the fifth edition in Kalorama’s ongoing series, offers unparalleled access to insights on the trends and technologies that will define the industry's future. This report is essential for: Identifying market gaps and opportunities for product innovation. Gaining a competitive edge with strategic insights into the U.S. diagnostic landscape. Making informed...Published: November 19, 2024 | Price: $6,300.00 – $12,600.00
Stay Ahead of the Curve with Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029: With the global demand for infectious disease IVD products projected to surge, understanding market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern. Abstract As infectious diseases continue to pose significant global health challenges, diagnostic testing has emerged as a vital tool...Published: October 8, 2024 | Price: $6,300.00 – $12,600.00
Act Now – Be Prepared for Tomorrow’s IVD Market Don’t miss your chance to leverage Kalorama Information’s expert insights. Equip your business with the knowledge to anticipate changes, optimize product development, and maximize your strategies in the dynamic IVD landscape. Ready to take action? Purchase the IVD Test Procedure Volumes, 2024-2029 report today and secure your competitive advantage in this billion-dollar industry. Abstract Kalorama Information's IVD Test Procedure Volumes, 2024-2029 report provides a deep dive into the global trends...Published: August 29, 2024 | Price: $8,750.00 – $17,500.00
Kalorama Information's The Worldwide Market for In Vitro Diagnostic (IVD) Tests, now in its 17th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2024 to 2029, and essential insights needed to understand the IVD market in its entirety. With every significant test category covered in detail, it's like having ten market research reports in one comprehensive volume. Key Features: Extensive Coverage: Detailed estimates and...Published: April 23, 2024 | Price: $7,000.00 – $14,000.00
NOW IN ELEVEN EDITIONS—The Worldwide Market for Point-of-Care (POC) Diagnostic Tests forecasts the POC market through 2028. Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in vitro diagnostics (IVD) industry. However, the point-of-care (POC) segment is seen as a key growth area. Point-of-care refers to tests that can provide meaningful results during a provider visit or in the patient's home. Over the past two decades, Kalorama Information has observed that POC tests present significant...Published: March 7, 2024 | Price: $5,000.00 – $10,500.00
Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has been covering mPOC on a regular basis since 2013. Our latest report, The Market and Future Potential for Molecular Point-of-Care (mPOC),...Published: February 22, 2024 | Price: $5,000.00 – $10,500.00
Vaccines offer long-term or permanent immunity against diseases. They have been a cornerstone of preventive medicine for over 70 years, stimulating an immune response to specific diseases. The widespread adoption of effective vaccines has led to the near-elimination of many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Thanks to public vaccination programs, vaccine-preventable diseases and related deaths are now rare in developed nations and decreasing globally. Smallpox has been eradicated, polio eliminated...Published: December 19, 2023 | Price: $3,750.00 – $7,500.00
Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market. The market was both boosted and challenged in unexpected ways by COVID-19. But where does the multi-billion-dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th Edition, reveals that post-pandemic the market remains ripe with opportunity, notably in the areas of infectious diseases, cancer, and transplant diagnostics. Global demand persists, with...Published: November 27, 2023 | Price: $5,000.00 – $10,000.00
Telehealth and remote patient monitoring have become integral to improving health conditions and preventing health complications. The transformations observed during the pandemic have bolstered telemedicine and, consequently, remote patient monitoring, instilling confidence in virtual patient assessment and access to advanced technological monitoring. Since January 2019, remote patient monitoring has experienced a significant surge, and current telehealth systems are leveraging key technologies increasingly prevalent in the health industry to foster further growth. Kalorama Information analyzes these trends and more in Remote...Published: November 7, 2023 | Price: $3,750.00 – $7,500.00
In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors...Published: October 27, 2023 | Price: $5,000.00 – $10,000.00
In vitro diagnostics is a global market estimated to consist of over $120 billion. With less than half that revenue earned in the United States, an assessment of regional and country IVD markets is needed for successful business planning. Kalorama's 30 Country IVD Market Atlas report is designed to provide you with international market detail at the country-level to help improve your forecast modeling and planning. Whether you need Latin America, Middle East, APAC or Eastern Europe, this report has...Published: September 22, 2023 | Price: $6,000.00 – $12,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests and the future potential. In the process, pricing analysis is also performed. This report...Published: August 24, 2023 | Price: $8,750.00 – $17,500.00
"The most trusted and essential report on the global IVD industry." For Two Decades, One Volume Has Offered Complete Coverage of the IVD Industry The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry. Having a guide for the state of IVD and its future is a vital part of making well-informed decisions. The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic...Published: June 6, 2023 | Price: $5,000.00 – $10,000.00
This new Kalorama Information report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023, examines a range of both at-home tests and home collection tests. The At-Home in vitro diagnostic (IVD) testing market is comprised of IVD tests that can be purchased at the local store or on the Internet where the patient gathers the specimen and results are displayed usually within minutes. Generally, these are lateral flow technology or dip stick methods. [caption id="attachment_19849"...Published: April 24, 2023 | Price: $5,000.00 – $10,000.00
Covid-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in COVID-19 Testing Markets, 2023. The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of...Published: April 13, 2023 | Price: $6,000.00 – $12,000.00
The point-of-care diagnostics market has long been the opportunity market within IVD. Kalorama publishes a full-scope market research study annually on point of care (POC) devices that can test near the patient for maximum benefit to healthcare encounters. While tests run on lab-based analyzers, remain the bedrock of IVD revenues, point of care has always been seen as the growth area. There are more companies in the point of care market, and it is a top segment of investment. Now...Published: March 17, 2023 | Price: $3,750.00 – $7,500.00
Diagnostic testing continues to be a valuable resource to help physicians arrive at a diagnosis. Additionally, it has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. Now, in the aftermath of the COVID-19 pandemic, new products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture but one that remains resilient. Ultimately, the...Published: February 7, 2023 | Price: $5,000.00 – $10,000.00
This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market. The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market. Knowing these markets is essential to knowing the opportunity in point of care testing and microbiology IVD. Since 2013, Kalorama has been producing a dedicated...Published: January 23, 2023 | Price: $5,000.00 – $10,000.00
This report, The Market for In Vitro Diagnostic (IVD) Tests in Latin America, focuses on the market for reagents and instruments in the most important countries of the region. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis; the countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay were also considered to provide a complete overview of the region. Combined, these...Published: November 17, 2022 | Price: $5,000.00 – $10,000.00
What’s Driving Growth in the IVD Market in Q3 and the last half of 2022? What Major Trends are Affecting the Market in Q3 and the last half of 2022? How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2022? What Product Trends and New Developments Will Shape the IVD Market in the last half of 2022? Diagnostic test products have never been more important. This report is an update of the...Published: October 18, 2022 | Price: $5,000.00 – $10,000.00
The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies. This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three...Published: October 6, 2022 | Price: $5,000.00 – $10,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition, discusses the trends shaping the present and future of the IVD...Published: September 23, 2022 | Price: $5,000.00 – $10,000.00
V A C C I N E M A R K E T E X C E E D S $200 B I L L I O N In 2022, the global market for preventive vaccines is valued at $202.6 billion. That's up from $34.1 billion in 2017, and just $25 billion in 2010. Infectious diseases are some of the deadliest diseases that pose significant risk to human life. Sales increased from $127.6 billion in 2021 to $202.6 billion in...Published: May 5, 2022 | Price: $10,000.00
NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests Report, World Molecular Diagnostics Report or Molecular Point-of-Care (POC) report. All in any edition. This is because this is a quarterly update to markets covered in these reports. The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel...Published: April 28, 2022 | Price: $6,000.00 – $12,000.00
As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations...Published: April 19, 2022 | Price: $3,750.00 – $7,500.00
This report, COVID-19 Testing Market Update, 2022, provides market sizing and estimates for COVID-19 tests with some discussion of market impacts of COVID-19. The scourge of COVID-19 continued to occupy laboratories and the in vitro diagnostic (IVD) companies that serve them throughout 2021 and into 2022. Testing already present in large labs and clinics entered the home last year, which added to market revenues. There was 33 BN of revenues in 2021, and the report details the share of antigen,...Published: April 7, 2022 | Price: $6,000.00 – $12,000.00
The Most Comprehensive and Reliable Market Sizing and Forecasts in Infectious Disease IVD [caption id="attachment_18836" align="aligncenter" width="300"] Attend a WEBINAR on this topic.[/caption] Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the...Published: March 29, 2022 | Price: $3,750.00 – $7,500.00
The at-home IVD testing market is a growing market with much potential. This report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), analyzes at-home tests where the entire process is done at home. A sample is collected, and the results are provided in under one hour. This does not include self-collection at home and then sent to a laboratory where it can be analyzed. This report is segmented into three areas: Glucose Infectious disease Other...Published: March 23, 2022 | Price: $5,000.00 – $10,000.00
What’s Driving Growth in the IVD Market in 2022? What Major Trends are Affecting the Market in 2022? How Has COVID-19 Impacted and Continued to Impact the Market in 2022? What Product Trends and New Developments Will Shape the IVD Market in 2022? Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama’s analysts to reflect the latest information as of Q1 2022. The demand for testing...Published: January 21, 2022 | Price: $5,000.00 – $10,000.00
Kalorama Information has covered digital pathology markets in line with its coverage of related in vitro diagnostic tests for over a decade. This 2022 edition, Global Digital Pathology Markets, clarifies the market situation given recent changes due to COVID-19’s lingering presence and impact. The report provides: Market for Digital Pathology, Now and in 2026 Position of Major Players Regional Analysis Trends – Market Drivers and Limiters Trends – Artificial Intelligence (AI) Trends – Quantum Computing Scanners Market Software and Other...Published: January 5, 2022 | Price: $3,750.00 – $7,500.00
This new Kalorama Information report, World Market for Blood Screening, focuses on the evolving, multibillion dollar global blood screening market. Blood screening is a medical process that scans the blood for infectious diseases or conditions. In developed nations, donated blood is screened for various pathogens. It is a mature market; however, growth comes from new technologies, increased volume and increased testing in developing nations. Blood screening testing’s primary objectives are to monitor the appearance of newly discovered infectious agents in...Published: September 29, 2021 | Price: $3,000.00 – $6,000.00
Allergies are a number of conditions that are caused by hypersensitivity to a substance in the environment. Allergies can run the gamut of seasonal nuisances to life-threatening ordeals. Allergy statistics show that these conditions are constantly present in lives and are not going away. Factors contributing to allergies worldwide include: Environmental pollution Changing lifestyles and dietary patterns Indoor pollution An individual who is overly reactive to an antigen that is tolerated by most others is said to be hypersensitive (allergic). ...Published: September 29, 2021 | Price: $4,000.00 – $8,000.00
As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. China as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over...Published: September 29, 2021 | Price: $3,000.00 – $6,000.00
A considerable number of diagnostic tests are available or in development for the detection of autoimmune diseases. Because of this potentially large and growing market, vast opportunity exists for discovery and advancement in this arena. Competition within this market is expected to increase dramatically. However, in fledgling autoimmune IVD diagnostic testing markets, a golden opportunity exists to capitalize on new testing innovations without significant competition. In terms of test options, a substantial amount of overlap exists in the various autoimmune...Published: June 7, 2021 | Price: $4,000.00 – $8,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. COVID-19 had a profound effect on the IVD diagnostic industry – some segments exploded and others languished. At this point in time, it is hard to predict...Published: April 15, 2021 | Price: $3,000.00 – $6,000.00
This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present – March 31, 2021. For the purpose of this report, Kalorama Information concludes that the accepted definition of a home or...